Huyang Xie

Publication Activity (10 Years)

Years Active: 2017-2018
Publications (10 Years): 4

Top Topics

Patient Reported

Prognostic Factors

Muscle Invasive Bladder Cancer

Top Venues

Scientific reports

Clinical cancer research : an official journal of the American Association for Cancer Research

Nantong Tumor Hospital

Fudan University Shanghai Cancer Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nantong Tumor Hospital

China

Resident :: General Surgery

Education History

Fudan University Shanghai Cancer Center Sep 01 2014 - Jun 26 2018

China

PHD :: Urology

Fudan University Shanghai Cancer Center

China

MSC :: Urology

Tongji University Medical College

China

BSC

Publications

Hangcheng Fu, Yu Zhu, Yiwei Wang, Zheng Liu, Junyu Zhang, Huyang Xie, Qiang Fu, Bo Dai, Dingwei Ye, Jiejie Xu
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (13) (2018)
Zheng Liu, Yu Zhu, Le Xu, Junyu Zhang, Huyang Xie, Hangcheng Fu, Quan Zhou, Yuan Chang, Bo Dai, Jiejie Xu
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer. Oncoimmunology 7 (9) (2018)
Fujiang Xu, Kun Chang, Jian Ma, Yuanyuan Qu, Huyang Xie, Bo Dai, Hualei Gan, Hailiang Zhang, Guohai Shi, Yao Zhu, Yiping Zhu, Yijun Shen, Dingwei Ye
Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma. Scientific reports 8 (1) (2018)
Fujiang Xu, Kun Chang, Jian Ma, Yuanyuan Qu, Huyang Xie, Bo Dai, Hualei Gan, Hailiang Zhang, Guohai Shi, Yao Zhu, Yiping Zhu, Yijun Shen, Dingwei Ye
The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma. Scientific reports 7 (1) (2017)